查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1631382

骨和關節的健康補充品的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2025年～2032年)

Bone and Joint Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 176 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2025 年全球骨關節保健品市場規模將達到 112 億美元，2025-2032 年預測期間複合年增長率為 9.3%，到 2032 年將達到 208 億美元。

骨骼和關節保健補充劑提供多種解決方案，幫助控制骨質疏鬆症、關節炎和一般關節疼痛等疾病，這對於維持和改善肌肉骨骼健康發揮著重要作用。這些補充劑含有葡萄糖胺、軟骨素、鈣、維生素 D 和膠原蛋白等成分，通常用於支持骨密度和關節靈活性。該市場面向世界各地的消費者，產品以多種形式銷售，包括片劑、膠囊、粉末和液體製劑。骨骼和關節健康意識的提高、全球人口老化以及對預防性醫療解決方案的需求不斷增加推動了市場成長。

全球骨關節保健品市場受到幾個關鍵因素的推動，包括骨關節炎和類風濕性關節炎等關節相關疾病的盛行率上升，特別是在老化人口中。消費者對骨骼健康重要性的認識不斷提高，加上對天然和預防性補充劑的需求不斷增長，進一步推動了市場擴張。補充劑配方的技術進步，包括開發基於膠原蛋白和基於植物的替代品，為市場成長提供了新的機會。此外，人們對運動營養和健康的興趣日益濃厚，也推動了對關節保健產品的需求，尤其是年輕人。

由於個人化營養的新興趨勢以及擴大採用電子商務平台進行產品分銷，骨骼和關節保健品市場提供了巨大的成長機會。研究進展正在發現可增強骨骼和關節補充劑功效的新成分和配方，例如生物可利用的膠原蛋白和植物性替代品。策略夥伴關係、研發投資以及針對特定族群（例如運動員、老年人和慢性關節痛患者）推出解決方案，是佔領新細分市場的重要機會。此外，預防性醫療保健的成長趨勢為成熟市場和新興市場提供了成長機會。

本報告提供全球骨和關節的健康補充品市場相關調查，提供不同形態，各終端用戶，各流通管道，成分各類型，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 骨和關節的健康補充品市場產業結構

第4章 骨和關節的健康補充品市場觀點

  • 宏觀經濟要素
  • 機會分析
  • 世界經濟預測
  • 主要的法規Scenario
  • 市場動態
  • 市場趨勢

第5章 全球骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)，各地區

第6章 全球骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)，不同形態

第7章 全球骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)，各終端用戶

第8章 全球骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)，各流通管道

第9章 全球骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)，成分各類型

第10章 北美的骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)

第11章 南美的骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)

第12章 歐洲的骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)

第13章 亞太地區的骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)

第14章 中東·非洲的骨和關節的健康補充品市場分析(2019年～2024年)及預測(2025年～2032年)

第15章 預測要素:相關性及影響

第16章 競爭情形(廠商/供應商)

  • 競爭儀表板
  • 競爭的發展(合併，收購，擴大)
  • 音量佔有率分析
  • 競爭詳細內容
    • Koninklijke DSM N.V.
    • Glanbia PLC
    • Bayer AG
    • Kerry Group PLC
    • BASF SE
    • Alticor Inc.
    • NOW Health Group, Inc.
    • USANA Health Sciences, Inc.
    • Nutramax Laboratories, Inc.
    • Herbalife International
    • Nature's Bounty Co.
    • Abbott Laboratories
    • Bio-Tech Pharmacal Inc.
    • Seroyal International Inc.
    • NutriGold Inc.
    • 其他

第17章 所使用的假設和縮寫

第18章 調查手法

簡介目錄
Product Code: PMRREP23539

Persistence Market Research has recently released a comprehensive report on the worldwide Bone and Joint Health Supplements Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bone and joint health supplements market from 2025 to 2032.

Key Insights:

  • Bone and Joint Health Supplements Market Size (2025E): USD 11.2 Billion
  • Projected Market Value (2032F): USD 20.8 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Bone and Joint Health Supplements Market - Report Scope:

Bone and joint health supplements play a crucial role in maintaining and improving musculoskeletal health, offering various solutions to help manage conditions such as osteoporosis, arthritis, and general joint pain. These supplements include ingredients like glucosamine, chondroitin, calcium, vitamin D, and collagen, which are commonly used to support bone density and joint flexibility. The market caters to consumers worldwide, with products available in various forms such as tablets, capsules, powders, and liquid formulations. Market growth is driven by increasing awareness of bone and joint health, the aging global population, and rising demand for preventive healthcare solutions.

Market Growth Drivers:

The global bone and joint health supplements market is propelled by several key factors, including the growing prevalence of joint-related disorders, such as osteoarthritis and rheumatoid arthritis, particularly among the aging population. Increased consumer awareness about the importance of bone health, coupled with the rising demand for natural and preventive supplements, further drives market expansion. Technological advancements in supplement formulations, including the development of collagen-based and plant-based alternatives, offer new opportunities for market growth. Moreover, the surge in interest in sports nutrition and wellness also fuels demand for joint health products, particularly among younger populations.

Market Restraints:

Despite promising growth prospects, the bone and joint health supplements market faces challenges related to regulatory hurdles, especially concerning the approval and claims made by supplement manufacturers. Concerns about the safety and efficacy of certain ingredients, such as glucosamine and chondroitin, can hinder consumer confidence in these products. Additionally, high market competition and the presence of counterfeit products pose challenges for manufacturers to maintain market share and ensure product quality. Limited healthcare coverage for non-prescription supplements in some regions may also affect consumer access and market penetration.

Market Opportunities:

The bone and joint health supplements market presents significant growth opportunities driven by emerging trends in personalized nutrition and the increasing adoption of e-commerce platforms for product distribution. Advances in research are unlocking new ingredients and formulations that enhance the efficacy of bone and joint supplements, such as bioavailable collagen and plant-based alternatives. Strategic partnerships, investment in R&D, and the introduction of targeted solutions for specific demographics, such as athletes, the elderly, and individuals with chronic joint pain, are key opportunities to capture new market segments. Furthermore, the growing trend toward preventive healthcare presents a lucrative opportunity for growth in both established and emerging markets.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bone and joint health supplements market globally?
  • Which ingredients and supplement forms are driving adoption in the market?
  • How are technological advancements in supplement formulations reshaping the competitive landscape?
  • Who are the key players contributing to the bone and joint health supplements market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global bone and joint health supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global bone and joint health supplements market, including companies like Glanbia Nutritionals, Abbott Laboratories, and Nature's Bounty, focus on product innovation, marketing strategies, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop new and effective formulations, such as advanced collagen peptides and plant-based supplements. Collaborations with healthcare professionals, fitness influencers, and e-commerce platforms are helping market players reach a broader audience. Moreover, educating consumers on the benefits of joint health supplements through clinical research and direct-to-consumer marketing is driving brand loyalty and customer retention.

Key Companies Profiled:

  • Glanbia Nutritionals
  • Abbott Laboratories
  • Nature's Bounty
  • Herbalife Nutrition Ltd.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
  • Amway Corporation
  • Omega Protein Corporation
  • Nestle Health Science
  • Solgar Inc.

Market Segmentation

By Form

  • Soft Gels/Pills
  • Powder
  • Liquid

By End User

  • Men
  • Women
  • Senior Citizen

By Distribution Channel

  • Pharmacies Drug Stores
  • Health & Beauty Stores
  • Specialty Stores
  • Online Sales

By Ingredient Type

  • Vitamins & Minerals
  • Amino Acids
  • Botanical Supplements

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Bone and Joint Health Supplements Market Industry Structure

  • 3.1. Market Structure
  • 3.2. Parent Market Overview
  • 3.3. Value Chain

4. Bone and Joint Health Supplements Market View Point

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis
  • 4.3. Global Economic Outlook
  • 4.4. Key Regulations Scenario
  • 4.5. Market Dynamics
  • 4.6. Market Trends
    • 4.6.1. Past Trends
    • 4.6.2. Forecast Trends

5. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Region

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size (US$ Bn) and Volume Analysis By Region, 2019 - 2024
  • 5.3. Market Size (US$ Bn) and Volume Forecast By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Latin America
    • 5.3.3. Europe
    • 5.3.4. Asia Pacific
    • 5.3.5. Middle East & Africa
  • 5.4. Market Attractiveness Analysis By Region

6. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Form

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Bn) and Volume Analysis By Form (2019 - 2024)
  • 6.3. Market Size (US$ Bn) and Volume Forecast By Form (2025 - 2032)
    • 6.3.1. Soft Gels/Pills
    • 6.3.2. Powder
    • 6.3.3. Liquid
  • 6.4. Market Attractiveness Analysis By Application

7. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By End User

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Bn) and Volume Analysis By End User (2019 - 2024)
  • 7.3. Market Size (US$ Bn) and Volume Forecast By End User (2025 - 2032)
    • 7.3.1. Men
    • 7.3.2. Women
    • 7.3.3. Senior Citizen
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis By End User

8. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Distribution Channel

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Bn) and Volume Analysis By Distribution Channel (2019 - 2024)
  • 8.3. Market Size (US$ Bn) and Volume Forecast By Distribution Channel (2025 - 2032)
    • 8.3.1. Pharmacies Drug Stores
    • 8.3.2. Health & Beauty Stores
    • 8.3.3. Specialty Stores
    • 8.3.4. Online Sales
    • 8.3.5. Other Sales Channel
  • 8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Ingredient Type

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Bn) and Volume Analysis By Ingredient Type (2019 - 2024)
  • 9.3. Market Size (US$ Bn) and Volume Forecast By Ingredient Type (2025 - 2032)
    • 9.3.1. Vitamins & Minerals
    • 9.3.2. Amino Acids
    • 9.3.3. Botanical Supplements
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis By Nature

10. North America Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 10.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Form
    • 10.3.3. By End User
    • 10.3.4. By Distribution Channel
    • 10.3.5. By Ingredient Type
  • 10.4. Drivers and Restraints: Impact Analysis
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Form
    • 10.5.3. By End User
    • 10.5.4. By Distribution Channel
    • 10.5.5. By Ingredient Type

11. Latin America Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 11.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Argentina
      • 11.3.1.4. Rest of Latin America
    • 11.3.2. By Form
    • 11.3.3. By End User
    • 11.3.4. By Distribution Channel
    • 11.3.5. By Ingredient Type
  • 11.4. Drivers and Restraints: Impact Analysis
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Form
    • 11.5.3. By End User
    • 11.5.4. By Distribution Channel
    • 11.5.5. By Ingredient Type

12. Europe Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 12.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. Rest of Europe
    • 12.3.2. By Form
    • 12.3.3. By End User
    • 12.3.4. By Distribution Channel
    • 12.3.5. By Ingredient Type
  • 12.4. Drivers and Restraints: Impact Analysis
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Form
    • 12.5.3. By End User
    • 12.5.4. By Distribution Channel
    • 12.5.5. By Ingredient Type

13. Asia Pacific Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 13.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 13.3.1. By Country
      • 13.3.1.1. China
      • 13.3.1.2. India
      • 13.3.1.3. Japan
      • 13.3.1.4. ASEAN
      • 13.3.1.5. Australia & New Zealand
      • 13.3.1.6. Rest of APAC
    • 13.3.2. By Form
    • 13.3.3. By End User
    • 13.3.4. By Distribution Channel
    • 13.3.5. By Ingredient Type
  • 13.4. Drivers and Restraints: Impact Analysis
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Form
    • 13.5.3. By End User
    • 13.5.4. By Distribution Channel
    • 13.5.5. By Ingredient Type

14. Middle East & Africa Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume Analysis By Price Range (2019 - 2024)
  • 14.3. Market Size (US$ Bn) and Volume Forecast By Price Range (2025 - 2032)
    • 14.3.1. By Country
      • 14.3.1.1. GCC Countries
      • 14.3.1.2. Northern Africa
      • 14.3.1.3. South Africa
      • 14.3.1.4. Rest of MEA
    • 14.3.2. By Form
    • 14.3.3. By End User
    • 14.3.4. By Distribution Channel
    • 14.3.5. By Ingredient Type
  • 14.4. Drivers and Restraints: Impact Analysis
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Form
    • 14.5.3. By End User
    • 14.5.4. By Distribution Channel
    • 14.5.5. By Ingredient Type

15. Forecast Factors: Relevance and Impact

16. Competition Landscape (Manufacturers/Suppliers)

  • 16.1. Competition Dashboard
  • 16.2. Competition Developments (Mergers, Acquisitions and Expansions)
  • 16.3. Volume Share Analysis
  • 16.4. Competition Deepdive
    • 16.4.1. Koninklijke DSM N.V.
      • 16.4.1.1. Overview
      • 16.4.1.2. Product Portfolio
      • 16.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.1.4. Sales Footprint
      • 16.4.1.5. Strategy Overview
    • 16.4.2. Glanbia PLC
      • 16.4.2.1. Overview
      • 16.4.2.2. Product Portfolio
      • 16.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.2.4. Sales Footprint
      • 16.4.2.5. Strategy Overview
    • 16.4.3. Bayer AG
      • 16.4.3.1. Overview
      • 16.4.3.2. Product Portfolio
      • 16.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.3.4. Production Footprint
      • 16.4.3.5. Sales Footprint
      • 16.4.3.6. Strategy Overview
    • 16.4.4. Kerry Group PLC
      • 16.4.4.1. Overview
      • 16.4.4.2. Product Portfolio
      • 16.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.4.4. Production Footprint
      • 16.4.4.5. Sales Footprint
      • 16.4.4.6. Strategy Overview
    • 16.4.5. BASF SE
      • 16.4.5.1. Overview
      • 16.4.5.2. Product Portfolio
      • 16.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.5.4. Sales Footprint
      • 16.4.5.5. Strategy Overview
    • 16.4.6. Alticor Inc.
      • 16.4.6.1. Overview
      • 16.4.6.2. Product Portfolio
      • 16.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.6.4. Sales Footprint
      • 16.4.6.5. Strategy Overview
    • 16.4.7. NOW Health Group, Inc.
      • 16.4.7.1. Overview
      • 16.4.7.2. Product Portfolio
      • 16.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.7.4. Sales Footprint
      • 16.4.7.5. Strategy Overview
    • 16.4.8. USANA Health Sciences, Inc.
      • 16.4.8.1. Overview
      • 16.4.8.2. Product Portfolio
      • 16.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.8.4. Sales Footprint
      • 16.4.8.5. Strategy Overview
    • 16.4.9. Nutramax Laboratories, Inc.
      • 16.4.9.1. Overview
      • 16.4.9.2. Product Portfolio
      • 16.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.9.4. Sales Footprint
      • 16.4.9.5. Strategy Overview
    • 16.4.10. Herbalife International
      • 16.4.10.1. Overview
      • 16.4.10.2. Product Portfolio
      • 16.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.10.4. Sales Footprint
      • 16.4.10.5. Strategy Overview
    • 16.4.11. Nature's Bounty Co.
      • 16.4.11.1. Overview
      • 16.4.11.2. Product Portfolio
      • 16.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.11.4. Sales Footprint
      • 16.4.11.5. Strategy Overview
    • 16.4.12. Abbott Laboratories
      • 16.4.12.1. Overview
      • 16.4.12.2. Product Portfolio
      • 16.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.12.4. Sales Footprint
      • 16.4.12.5. Strategy Overview
    • 16.4.13. Bio-Tech Pharmacal Inc.
      • 16.4.13.1. Overview
      • 16.4.13.2. Product Portfolio
      • 16.4.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.13.4. Sales Footprint
      • 16.4.13.5. Strategy Overview
    • 16.4.14. Seroyal International Inc.
      • 16.4.14.1. Overview
      • 16.4.14.2. Product Portfolio
      • 16.4.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.14.4. Sales Footprint
      • 16.4.14.5. Strategy Overview
    • 16.4.15. NutriGold Inc.
      • 16.4.15.1. Overview
      • 16.4.15.2. Product Portfolio
      • 16.4.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.15.4. Sales Footprint
      • 16.4.15.5. Strategy Overview
    • 16.4.16. Others
      • 16.4.16.1. Overview
      • 16.4.16.2. Product Portfolio
      • 16.4.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.16.4. Sales Footprint
      • 16.4.16.5. Strategy Overview

17. Assumptions and Acronyms Used

18. Research Methodology